March 11, 2010 Thursday
13:00-14:00 Arrival and registration
M. Alpay Ateş
  Soundar Regunathan
Moderator: Feyza Arıcıoğlu
  Agmatine: a novel endogenous molecule with multiple functions
16:00-16:30 Tea & Coffee Break
16:30-18:00 M*-1: Current algorithms in the treatment of psychiatric disorders
  Discussant Moderators: Erdal Işık, İsmail Ak
Özcan Uzun
Mood disorders
Haluk Savaş
Anxiety disorders
Nesrin Dilbaz
Addictions and pain disorders Tahir Tellioğlu
  Angelos Halaris
Moderator: Sunar Birsöz
  Cardiovascular dysfunction in depression: effects of treatment
Evaluations and lessons learned M. Alpay Ateş
20:00-21:00 Welcome reception
March 12, 2010 Friday
08:00-19:00 Registration
09:00-10:45 M-2: From epigenetics to genetics and pharmacogenetics: is mental health a fate or acquisition?
  Discussant Moderators: M. Emin Ceylan, Cengiz Başoğlu
What is more important in etiopathogenesis of mental disorders:
genetics or epigenetics?
Hasan Herken
Why do drugs not affect everyone in the same way?
Is personalized medicine an utopia or real?
Reflections of genetic polymorphism on clinical care and treatment
Ümit Yaşar
Malpractice cases encountered as a result of drug interactions in psychopharmacology: the don'ts
Selçuk Kırlı
Psychiatric side effects of nonpsychotropic drugs: provoking situations for these side effects and management of them Nazan Aydın
10:45-11:00 Tea & Coffee Break
  John Krystal
Moderator: İlhan Yargıç
  Glutamate and alcoholism vulnerability: insights into new treatment approaches
12:15-13:00 Lunch
13:00-14:00 Industry Supported Satellite symposium (Janssen Cilag)
Is it possible to make a difference in the treatment of Schizophrenia?

Nesrin Dilbaz
Ali Saffet Gönül
Ömer Aydemir

Oğuz Karamustafalıoğlu
14:00-14:30 Tea & Cofee Break
14:30-16:30 M-3: New dimensions, new developments and new horizons in etiopathogenesis and treatment of psychiatric disorders: agmatine, glutamate,dopamine and others
  Discussant Moderators: Feyza Arıcıoğlu, Serdar Dursun
Agmatinergic system in neuropsychiatric disorders
Soundar Regunathan
Glutamate, the prefrontal cortex, and schizophrenia:
the search for alternatives to dopaminergic antipsychotics
John Krsytal
New dimensions, new developments and new horizons in psychopharmacology: partial agonists in dependency treatment
Tahir Tellioğlu
Translational approaches toward developing novel psychotherapeutic agents Angelos Halaris
16:30-17:00 Break
  Joseph Zohar
Moderator: Oğuz Karamustafalıoğlu
  Challenging the myths in PTSD: focus on early and long term pharmacological intervention
Evaluations and lessons learned

M. Alpay Ateş

20:30-22:00 Workshops, courses, and other scientific activities
Hall 1 C-2: Joseph Zohar - Oğuz Karamustafalıoğlu OCD and its treatment: current concepts and novel approaches
Hall 2 W*-1: Tahir Tellioğlu Addiction and pain: early diagnosis and treatment of substance dependent patients, differential diagnosis techniques for genuine pain patients and substance dependents
Hall 3 C*-1: Serdar Dursun Basic principles of research project (grant) writing and obtaining funds
March 13, 2010 Saturday
09:00-10:30 M-4: Effectively and critically reading scientific articles, conducting scientific research, and techniques of manuscript preparation and publication
  Discussant Moderators: Samet Köse, Tahir Tellioğlu
How can we read a scientific article critically?
Rasim Somer Diler
Constructing the correct methodology in scientific research and common errors
Selim Kılıç
Statistics for scientific research: basic principles and common pitfalls. How can we detect misuse and abuse of statistics?
Cengiz Han Açıkel
The correct and effective techniques of preparing scientific manuscripts Murad Atmaca
10:30-11:00 Tea & Coffee Break
11:00-12:00 Industry Supported Satellite symposium (BMS)
Management of Inadequate Response to Antidepressants for Patients with Major Depressive Disorder

Speaker: George I. Papakostas
Director, Treatment-Resistant Depression Studies Department of Psychiatry
Massachusetts General Hospital
Associate Professor of Psychiatry Harvard Medical School

Moderator: Mesut Çetin
12:00-13:00 Lunch
13:00-14:00 Industry Supported Satellite symposium (AstraZeneca)
Improving Acute and Long Term Outcome in Schizophrenia
Speaker: Joseph Peuskens
President, University Psychiatric Centre
Medical Director, University Centre Saint Jozef Kortenberg
Professor, Universiteit Leuven

Moderator: Oğuz Karamustafalıoğlu
14:00-14:30 Tea & Coffee Break
14:30-16:30 M-5: Frequently encountered but not commonly known syndromes in psychiatric practice and their management
  Discussant Moderators: Engin Eker, Servet Ebrinç
Temperament based therapy modifications in ADHD and impulse control disorders
Tümer Türkbay
Current treatment approaches in adult ADHD.
Addiction potential, major side effects of stimulants, and dealing with them. Principles of lifetime use of stimulants
İlhan Yargıç
Differences between alcohol dependent patients in outpatient or inpatient treatment. Basic principles in psychopharmacology of alcohol and substance dependence
Cüneyt Evren
Evaluating treatment responses in patients with dementia, drug combinations and termination criteria for these drugs Işın Baral Kulaksızoğlu
16:30-17:00 Break
  Rasim Somer Diler
Moderator: Bengi Semerci
  Differential diagnosis of ADHD and Bipolar Disorder: treatment approaches in comorbid conditions
  Serdar Dursun
Moderator: Atila Erol
  Neuroscientific and clinical fundamentals of switching antipsychotic drugs
Evaluations and lessons learned

Ayhan Algül

20:30-22:00 Workshop, course and other scientific activities
Hall 1 W-2: Rasim Somer Diler Bipolar depression in children: is diagnosis or treatment more difficult?
Hall 2 W-3: Samet Köse Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Hall 3 W-3: Samet Köse Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
14 Mart 2010 Pazar / March 14, 2010 Sunday
09:00-10:45 M-6: Neuroimaging in psychiatric disorders in early diagnosis and follow-up of treatment and usage of neuroimaging in daily practice.
  Discussant Moderators: Kâzım Yazıcı, Kemal Sayar
Psyschosis as a brain integration disorder
Jack Foucher
What is current progression in neuroimaging? Promises in medicine and future projections
Gözde Ünal
How relevant is neuroimaging as a predictor in early diagnosis (in Alzheimer's disease, etc.) Traces of treatment in the brain
Ali Saffet Gönül
Psychiatric Neuroimaging: conceptual issues and promises on clinical decisions
Samet Köse
Evaluations and lessons learned

Ayhan Algül

11:00 Closing Remarks

* M: Module
* C:  Course
* W: Workshop

  LookUs & Online Makale

Psikofarmakoloji Sayaç